Lincoln Pharmaceuticals Limited · NSE: LINCOLN · BSE: 531633

Lincoln Pharmaceuticals

Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 13 Aug 2026.

Q1 FY27 · Consolidated

Revenue
177.28₹ Cr
+15.1% vs year ago
Net profit
36.23₹ Cr
+30.9% vs year ago
EPS, basic
18.09₹
+30.9% vs year ago
Net margin
20.4%
+2.5 pts vs year ago
Revenue₹ crore · consolidated · last 12 quarters
Q2 FY24: ₹155.99 CrQ3 FY24: ₹146.45 CrQ4 FY24: ₹142.49 CrQ1 FY25: ₹147.28 CrQ2 FY25: ₹161.21 CrQ3 FY25: ₹146.55 CrQ4 FY25: ₹168.18 CrQ1 FY26: ₹154.07 CrQ2 FY26: ₹163.36 CrQ3 FY26: ₹166.32 CrQ4 FY26: ₹187.28 CrQ1 FY27: ₹177.28 CrQ3 ’24Q1 ’25Q3 ’25Q1 ’26Q3 ’26Q1 ’27
Net profit₹ crore · consolidated · last 12 quarters
Q2 FY24: ₹27.65 CrQ3 FY24: ₹28.04 CrQ4 FY24: ₹18.60 CrQ1 FY25: ₹23.67 CrQ2 FY25: ₹26.33 CrQ3 FY25: ₹20.77 CrQ4 FY25: ₹11.57 CrQ1 FY26: ₹27.68 CrQ2 FY26: ₹19.98 CrQ3 FY26: ₹28.60 CrQ4 FY26: ₹11.63 CrQ1 FY27: ₹36.23 CrQ3 ’24Q1 ’25Q3 ’25Q1 ’26Q3 ’26Q1 ’27

Quarter by quarter

Consolidated · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 2026177.28+15.1%36.23+30.9%18.0913 Aug 2026
Q4 FY26Jan–Mar 2026187.28+11.4%11.63+0.5%5.8128 May 2026
Q3 FY26Oct–Dec 2025166.32+13.5%28.60+37.7%14.2812 Feb 2026
Q2 FY26Jul–Sep 2025163.36+1.3%19.98−24.1%9.9813 Nov 2025
Q1 FY26Apr–Jun 2025154.07+4.6%27.68+16.9%13.8207 Aug 2025
Q4 FY25Jan–Mar 2025168.18+18.0%11.57−37.8%5.7822 May 2025
Q3 FY25Oct–Dec 2024146.55+0.1%20.77−25.9%10.3713 Feb 2025
Q2 FY25Jul–Sep 2024161.21+3.4%26.33−4.8%13.1514 Nov 2024
Q1 FY25Apr–Jun 2024147.28+8.6%23.67+24.5%11.8223 Aug 2024
Q4 FY24Jan–Mar 2024142.49+26.7%18.60+48.0%9.2818 May 2024
Q3 FY24Oct–Dec 2023146.45+9.5%28.04+29.7%14.0021 Feb 2024
Q2 FY24Jul–Sep 2023155.99+10.9%27.65+16.6%13.8117 Nov 2023
Q1 FY24Apr–Jun 2023135.62+9.8%19.01+26.7%9.4910 Aug 2023
Q4 FY23Jan–Mar 2023112.46+9.6%12.56+13.9%6.2725 May 2023
Q3 FY23Oct–Dec 2022133.77—21.61—10.7910 Feb 2023
Q2 FY23Jul–Sep 2022140.61—23.71—11.8422 Nov 2022
Q1 FY23Apr–Jun 2022123.47—15.01—7.4923 Aug 2022
Q4 FY22Jan–Mar 2022102.59—11.02—5.5020 Jun 2022
Standalone results
Standalone · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 2026177.28+15.1%36.23+30.9%18.0913 Aug 2026
Q4 FY26Jan–Mar 2026187.28+11.4%11.63+0.5%5.8128 May 2026
Q3 FY26Oct–Dec 2025166.32+13.5%28.60+37.7%14.2812 Feb 2026
Q2 FY26Jul–Sep 2025163.36+1.3%19.98−24.1%9.9813 Nov 2025
Q1 FY26Apr–Jun 2025154.07+4.6%27.68+16.9%13.8207 Aug 2025
Q4 FY25Jan–Mar 2025168.18+18.0%11.57−37.8%5.7822 May 2025
Q3 FY25Oct–Dec 2024146.55+0.1%20.77−25.9%10.3713 Feb 2025
Q2 FY25Jul–Sep 2024161.21+3.4%26.33−4.8%13.1514 Nov 2024
Q1 FY25Apr–Jun 2024147.28+8.6%23.67+24.5%11.8223 Aug 2024
Q4 FY24Jan–Mar 2024142.49+26.7%18.60+48.0%9.2818 May 2024
Q3 FY24Oct–Dec 2023146.45+9.5%28.04+29.7%14.0021 Feb 2024
Q2 FY24Jul–Sep 2023155.99+10.9%27.65+16.6%13.8117 Nov 2023
Q1 FY24Apr–Jun 2023135.62+9.8%19.01+26.7%9.4910 Aug 2023
Q4 FY23Jan–Mar 2023112.46+9.7%12.56+13.9%6.2725 May 2023
Q3 FY23Oct–Dec 2022133.77+11.6%21.61+22.8%10.7910 Feb 2023
Q2 FY23Jul–Sep 2022140.61+11.9%23.71+3.6%11.8422 Nov 2022
Q1 FY23Apr–Jun 2022123.47+3.1%15.01−13.6%7.4923 Aug 2022
Q4 FY22Jan–Mar 2022102.54+32.2%11.02−7.0%5.5020 Jun 2022
Q3 FY22Oct–Dec 2021119.88+6.9%17.60+31.7%8.7911 Feb 2022
Q2 FY22Jul–Sep 2021125.64+2.7%22.88+13.3%11.4411 Nov 2021
Q1 FY22Apr–Jun 2021119.74+18.5%17.38+15.9%8.6910 Aug 2021
Q4 FY21Jan–Mar 202177.54+3.0%11.85+28.3%5.9225 May 2021
Q3 FY21Oct–Dec 2020112.19+17.3%13.37+31.4%6.6802 Feb 2021
Q2 FY21Jul–Sep 2020122.29+10.6%20.20+12.3%10.1003 Nov 2020
Q1 FY21Apr–Jun 2020101.03+6.8%14.99+23.2%7.5020 Aug 2020
Q4 FY20Jan–Mar 202075.26−2.8%9.23+28.7%4.6225 Jun 2020
Q3 FY20Oct–Dec 201995.64+18.1%10.18+7.7%5.0914 Feb 2020
Q2 FY20Jul–Sep 2019110.60+12.9%17.99+24.9%8.9919 Nov 2019
Q1 FY20Apr–Jun 201994.59−2.1%12.16−22.0%6.0817 Aug 2019
Q4 FY19Jan–Mar 201977.46—7.17—3.5907 Jun 2019
Q3 FY19Oct–Dec 201881.00—9.45—4.7312 Feb 2019
Q2 FY19Jul–Sep 201897.95—14.41—7.2021 Nov 2018
Q1 FY19Apr–Jun 201896.63—15.60—7.8020 Aug 2018

51 filings on record for this company.